50 results
8-K
EX-99.1
ATXI
Avenue Therapeutics Inc
26 Apr 24
Avenue Therapeutics Announces Reverse Stock Split
4:39pm
and abuse, false claims, transparency, health information privacy and security, and other healthcare laws and regulations; the effects of competition for our
8-K
EX-99.1
ATXI
Avenue Therapeutics Inc
18 Mar 24
Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights
4:10pm
, transparency, health information privacy and security, and other healthcare laws and regulations; the effects of competition for our product
424B3
ATXI
Avenue Therapeutics Inc
2 Feb 24
Prospectus supplement
12:00am
privacy and security and other healthcare laws and regulations;
the effects of competition for our product candidates and the potential for new products
8-K
EX-10.2
gsvu4yn4f pkylbib
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
424B4
3vcmqjigwatka6b 24pq
2 Nov 23
Prospectus supplement with pricing info
9:00am
FWP
eacnkzd9vi02tunb76
5 Oct 23
Free writing prospectus
5:05pm
FWP
fdimh2arxgc kfb
3 Oct 23
Free writing prospectus
5:47pm
424B3
5oomfe
28 Jun 23
Prospectus supplement
4:56pm
424B3
tsf8b44 yysmw64bfc0d
4 May 23
Prospectus supplement
4:30pm